HUM vs TXG · P/E 39, rev $117.76B vs rev $610.8M
Humana Inc (HUM) versus 10X Genomics Inc (TXG) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
10X Genomics Inc (TXG) is a health information services company listed on NASDAQ.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported TXG revenue for 2024-12-31 was $610.8M. Net income was -$182.6M. Revenue was down 1.3% from 2023-12-31 to 2024-12-31. TXG currently screens at market cap $4.08B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. TXG currently screens at market cap $4.08B.
Not investment advice. Open the HUM and TXG stock pages for the full models.
Not investment advice.